Owner Dyax Corp.

Inventors Ladner, Robert C.; Ley, Arthur C.; Hirani, Shirish; Williams, Anthony

Agent Davies Collison Cave

Pub. Number AU-A-2011201811

Parent 2008202377

Filing date 20 April 2011

Wipo publication date 19 May 2011

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 38/55 (2006.01) Medicinal preparations containing peptides - Protease inhibitors

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 41/00 (2006.01) Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 9/99 (2006.01) Enzymes, e.g. ligases (6.) - Enzyme inactivation by chemical treatment